Immune checkpoint protein may be a promising new target for prostate cancer immunotherapy – News-Medical.Net

The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers, according to two new studies led by researchers at the Johns Hopkins Kimmel Cancer Center. The studies were presented recently at…

Click here to view the original article.